文献速递遗传性与小管间质肾病慢性肾脏病

2024年Alport综合征国际研讨会更新报告

Update on Alport Syndrome: The Report of the 2024 International Workshop on Alport Syndrome.
PubMed 文献 · Kidney Int Rep · 2026-01-23

2024年Alport综合征国际研讨会汇集患者、临床医生、实验室科学家和药企代表,聚焦基因变异解读及从血尿到早期肾衰竭等不同表型的治疗策略。会议讨论了基因检测进展、新型疗法(基因治疗、SGLT2抑制剂和内皮素受体拮抗剂试验)及高收入与中低收入国家间的诊断差距。

要点

  • 基因检测进展尤其关注非欧洲人群,但变异解读和误分类仍是挑战。
  • SGLT2抑制剂和内皮素受体拮抗剂等药物试验及基因治疗为延长肾功能带来希望。
  • 需加强高收入与中低收入国家合作以缩小诊断能力差距。

核心结论

  • 随着研究进展,Alport综合征正接近成为可通过预防肾衰竭而高度可治疗的疾病。

研究设计与样本

  • 2024年Alport综合征国际研讨会汇集患者、临床医生、实验室科学家和药企代表,展示近期数据并讨论诊断与管理。

主要发现

  • 研讨会重点关注基因变异解读及从血尿到早期肾衰竭、伴或不伴听力损失和眼部异常的不同表型的治疗策略。
  • 基因检测进展尤其关注非欧洲人群,但变异解读和误分类仍存在挑战。
  • 基因治疗及SGLT2抑制剂和内皮素受体拮抗剂等药物试验为延长肾功能带来希望。
  • 会议强调高收入与中低收入国家合作以解决诊断能力差异,并重视患者倡导和肾脏病学教育。

临床怎么用

  • 临床应关注Alport综合征的基因变异解读,并考虑SGLT2抑制剂和内皮素受体拮抗剂等新型治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 2024 International Workshop on Alport syndrome brought together people living with Alport Syndrome, clinicians, laboratory scientists, and representatives of pharmaceutical companies to present recent data and discuss issues to advance understanding of this inherited condition. The workshop focused on diagnosis and management of Alport syndrome, with particular attention on genetic variant curation, and treatment strategies across the diverse spectrum of Alport syndrome phenotypes, from hematuria to early kidney failure, with or without hearing loss and eye abnormalities. Advances in genetic testing, especially for non-European populations, were discussed alongside challenges in variant interpretation and misclassification. Novel treatment approaches, including gene therapy, and ongoing trials of medications such as sodium-glucose cotransporter 2 inhibitors and endothelin receptor antagonists, offer hope for prolonging kidney function. Collaboration between high- and low-to-middle-income countries was highlighted, addressing disparities in diagnostic capabilities. In addition, the role of patient advocacy and the need for education in nephrology were emphasized. With ongoing research, Alport syndrome is moving closer to being not only actionable but highly treatable through the prevention of kidney failure.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Oates TM, Barua M, Gear S, et al. Update on Alport Syndrome: The Report of the 2024 International Workshop on Alport Syndrome. Kidney Int Rep. 2026. PMID: 41853742. doi:10.1016/j.ekir.2026.103785

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。